CRYO Stock UPDATES Cryo-Save Group N.V. (CRYO) 0.3600 08/20/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cryo-Save Group N.V. (CRYO) 0.3600 $CRYO

American CryoStem Enters Into Definitive Term Sheet With Health Innovative Technology Corporation Limited
GlobeNewswire - Wed Jul 02, 8:57AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that it has made a major step in establishing a global footprint for its cellular technology and laboratory processing platform by entering into an agreement to license its ATGRAFT(TM) adipose tissue (fat) processing and storage technologies with Health Innovative Technology Corporation Limited (HIT), a Hong Kong corporation. HIT currently operates a cellular processing and banking platform and a chain of medical centers, offering comprehensive healthcare solutions to clients in Hong Kong.

American CryoStem Announces Agreement With the nanoRANCH Division of UHV Technologies for Cancer Research Utilizing ATCELL(TM)
GlobeNewswire - Wed Jun 18, 9:17AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that the Company has entered into initial agreements with the nanoRANCH Division of UHV Technologies, Inc. ("nanoRANCH" for the development of methods for the delivery of therapeutics and drugs focused upon cancer treatments utilizing adipose derived adult stem cells. The Company will be working with Dan Dimitrijevich, PhD to create new treatment delivery methods utilizing a combination of nanoRANCH unique technology and CRYO's clinically processed ATCELLs(TM).

Rent-A-Center, Inc. Announces Fourth Quarter and Year End 2013 Earnings Call and Webcast
GlobeNewswire - Wed Jan 15, 11:16AM CST
Rent-A-Center, Inc. (Nasdaq:RCII) today announced it will host a conference call on Tuesday, January 28, at 10:45 a.m. ET to discuss fourth-quarter results slated for release following the market's close on January 27. Live audio of the conference call will be available on the company's investor relations website at http://investor.rentacenter.com. A replay will be available beginning January 28 at 1:45 p.m. ET.

American CryoStem Posts Letter to Shareholders
GlobeNewswire - Mon Jan 06, 12:45PM CST
John Arnone, Chairman and CEO of American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today issued a formal update in the form of a Letter to Shareholders posted to the Company's web site at www.americancryosystem.com.

Best's Rating Notification - Cincinnati Life Insurance Company
Rating Division - AMBest - Thu Dec 19, 1:14PM CST
A.M. Best Company has made the following rating update:

American Cryostem Granted Interlinked an Exclusive Interview During Recent FSXinterlinked Investment Conference
PRWeb - Tue Aug 27, 3:38AM CDT
At the recent FSXinterlinked Investment Conference, held at the Ritz Carloton in Fort Lauderdale, Florida, American Cryostem's Chairman and CEO, John Arnone, granted an exclusive interview for the FSXinterlinked channel on InterlinkedTV.

American CryoStem Granted IRB Approval for Adipose Derived Stem Cell Processing Protocols
GlobeNewswire - Wed Jul 10, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that its protocols for the processing of Stromal Vascular Fraction (SVF) and culturing of mesenchymal stem cells from autologous adipose tissue have been approved by the Institutional Review Board (IRB) of the International Cell Surgical Society (ICSS).

American CryoStem to Present at OneMedForumNY 2013
GlobeNewswire - Wed Jun 26, 8:35AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that the Company has been invited to present at OneMedForumNY 2013 to be held at the Metropolitan Club in New York City, June 26-27, 2013.

Under-valued Stem Cell Innovator Targets Growing Markets
ACCESSWIRE - Wed Jun 26, 8:00AM CDT
American CryoStem (CRYO) Targets Growing End Markets

American CryoStem Welcomes Noted Cryopreservation Expert, Dr. Dayong Gao, to Medical & Scientific Advisory Board
GlobeNewswire - Mon Jun 24, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that Dayong Gao, Ph.D. has been appointed to the Company's Medical and Scientific Advisory Board.

Fat Cells Lending to New Treatments in Brain Cancer
ACCESSWIRE - Thu Jun 13, 12:30PM CDT
Regenerative medicines hold incredible potential for new, more potent therapeutics to arrive in the future for a broad spectrum of diseases and conditions. As the industry in general is growing, more possibilities are emerging seemingly on a daily basis as research uncovers new ways to use stem cells to potentially combat deadly diseases like cancer where many patients have little to no hope with today's standards of care.

American CryoStem to Present at National Investment Banking Association's 126th Investment Conference
GlobeNewswire - Tue Jun 04, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced that the Company has been invited to present at the National Investment Banking Association's (NIBA) 126 Investment Conference to be held in New York City, June 17-19, 2013.

Investment Ideas in the Expanding Wound Care Market
ACCESSWIRE-TNW - Fri May 17, 10:55AM CDT
Investing in Wound Care's Real Growth Drivers

American CryoStem Partners with Rutgers for Novel Wound Care Product
ACCESSWIRE-TNW - Tue May 14, 11:01AM CDT
Regenerative medicine is constantly discovering new inroads to potential therapies utilizing adult stem cells for a variety of life threatening or debilitating conditions and diseases. Progress has accelerated in the past few years, fueled in part by President Obama's 2009 Executive Order 13505 that "removed barriers" in responsible research which has opened doors to examination of new ways of thinking. It has also aided in the emergence of research in the area of adipose (fat)-based stem cell therapy, which could prove to be a major breakthrough in regenerative medicine. Not only has early research at Johns Hopkins suggested the possibility of superior efficacy with Adipose-Derived Stem Cells, or ADSCs, in the treatment of glioblastoma (a severe form of brain cancer), but ADSCs are easily harvested, meaning that they could become a standard as the most reliable and abundant source of stem cells for research, cultures and therapeutic processes.

American CryoStem to Collaborate With Rutgers University on Adipose-Derived Stem Cell Research
GlobeNewswire - Tue May 14, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based and cellular technologies for the Regenerative and Personalized Medicine industries, today announced that it has entered into Material Transfer Agreements with three leading research scientists at Rutgers, The State University of New Jersey, distinguished as one of the world's premier universities for stem cell research and training.

The Beauty of American CryoStem Now and in the Future
ACCESSWIRE-TNW - Thu May 09, 1:12PM CDT
"What can I do with my unwanted body fat?" That is a question that is posed by American CryoStem (OTCQB: CRYO) on the home page of its website. There are plenty of finite resources in the world, but let's face it, body fat certainly isn't one of them. A little due diligence reveals the company's answer to that question, but a more discerning examination uncovers the true growth potential of American CryoStem from an immediate, mid-term and long-term perspective.

Use Your Own Stem Cells to Combat Aging Skin
ACCESSWIRE-TNW - Tue Apr 30, 5:12PM CDT
American Cryostem (OTCQB: CRYO) is a pioneer in the fields of regenerative and personalized medicine. Their multi-faceted business model involves the patented collection and storage of adipose-derived regenerative cells (ADRC's). The fat that is collected from the patient's own body can be used in cosmetic procedures like breast and buttock enhancements, which alone is a large market opportunity. However, a more intriguing proposition lies in the world of autologous, stem-cell based cosmetics treatments designed to combat the effects of aging on skin.

American CryoStem Marks Major Global Expansion Milestone: Receives First International Shipment of Adipose Tissue for Processing and Cryo-Storage From Hong Kong
GlobeNewswire - Tue Apr 23, 9:45AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced receipt of its first commercial international shipment of adipose tissue for processing and long term cryo-storage.

Adipose Derived Stem Cells Providing a Bridge to the Future of Regenerative Medicine
ACCESSWIRE-TNW - Thu Apr 18, 8:54AM CDT
Regenerative medicines are finally coming into their own as validated therapies for treatment of a wide spectrum of conditions and diseases. Years of research are now behind the industry and naysayers have been silenced with compilations of data demonstrating the use of stem cells to help the body heal itself. Of course, regenerative medicine is still relatively young and a moving target with new discoveries popping up and then being reinforced. A case in point is the recent work of Johns Hopkins University School of Medicine showing that mesenchymal stem cells derived from adipose (fat) tissue might be far more efficient in the treatment of glioblastoma, the most common form of brain cancer, than those derived from bone marrow, as scientists first thought. Cells derived from fat tissue can obviously be gathered in a far less invasive - and less expensive - manner.

American CryoStem to Exhibit at The Aesthetic Meeting
GlobeNewswire - Thu Apr 11, 7:30AM CDT
American CryoStem Corporation (OTCQB:CRYO), a leading biotech company in the field of Regenerative Medicine, today announced that the Company is scheduled to exhibit at The Aesthetic Meeting 2013, held this week, April 11-16 in New York City, at the Jacob Javits Convention Center. The Company will be showcasing its latest adipose tissue (fat) collection, processing and storage service, ATGRAFT(TM) and complimentary personalized skin care products. With one liposuction, ATGRAFT(TM) is a complete fat tissue storage solution for physicians to perform layered fat transfers and provides patients additional opportunities to use their stored fat tissue to create personalized skin care products or clinically processed stem cells for use in Regenerative Medicine treatments.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHP Global's Japan Move: A Major Toy Market Play

Updated Category News Views 93

New Horizons for Toys"R"Us in Japan Well, folks, look who's back in the toy game with a vengeance! WHP Global is shaking hands with Pan Pacific International Holdings (PPIH) to breathe new life into Toys"R"Us across Japan. Now PPIH isn’t just any player. We're talking about Japan's fourth-largest retailer, helming giants like Don Quijote and aiming to crown itself as...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 106

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Rock & Roll Hall of Fame's 2026 Induction Triumph

Updated Category News Views 158

A Night of Unstoppable Talent The Rock & Roll Hall of Fame's 2026 Induction Ceremony and boy, what a spectacle it was. Held on a lively Saturday night, November 14, in Los Angeles, it wasn't just an event; it was an electrifying testament to music's profound impact. With the grand ceremony kicking off at the historic city of stars, this year's induction turned the dial to...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 35

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
Thread AI Joins Microsoft Pegasus: Big AI Leap

Updated Category News Views 13

Thread AI Leaps Ahead with Microsoft Partnership There's excitement in the air as Thread AI joins forces with Microsoft by entering the exclusive Pegasus Program. In the ever-evolving world of AI, making a splash this big doesn't happen every day. People in the tech alley are buzzing, and it looks like Thread AI is ready to rumble on a larger stage—much like a scrappy...

Continue Reading
Nasdaq Tumbles: AI Hardware Pulls Markets Down

Updated Category News Views 49

Wall Street's Slide Fueled by AI Nerves The markets got a real jolt on Monday, sending Nasdaq down 2.5% thanks to a sharp dip in AI hardware stocks. Tech tickers tied to artificial intelligence were at the core of a sell-off, knocking the S&P 500 down 1.92% alongside it. Investors are on edge, and it’s not just the weather—it's a real shake-up driven by policy moves...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 199

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Engrain's Geospatial Innovation Pushes Property Mapping Forward

Updated Category News Views 118

Pushing the Boundaries of Property Mapping How far can you expand the boundaries of property mapping tech? Well, Engrain seems hell-bent on finding out by cranking their innovations up a notch. The Denver-based stalwart in interactive mapping is rolling out some mind-boggling enhancements that could redefine how the multifamily housing sector operates. This isn't just...

Continue Reading
Gold Tumbles: Kinross Faces Class Action Lawsuit

Updated Category News Views 120

Digging Deep into Kinross's Legal Fallout Well, here's a doozy for those investing in the precious metal market. Kinross Gold Corporation (NYSE: KGC) finds itself knee-deep in legal muck. Investors who bought into the Canadian gold miner's promises might be scrambling, as a class action lawsuit has just been lobbed their way. The culprit? A hefty drop-off in their...

Continue Reading
Fluence Energy Faces Heat: Class Action Lawsuit Unfolds

Updated Category News Views 73

Fluence Energy's Difficult Waters Investors in Fluence Energy (NASDAQ: FLNC) are having a moment of reckoning, no doubt. November 2nd saw a nearly 9% drop in FLNC stock, further fueled by the sudden departures of the CEO and CFO just days earlier. This marks a bitter chapter for Fluence as its stock continues to bleed, leaving many wondering what seismic shifts are yet to...

Continue Reading

Top 5 Most Recently Viewed Articles

Trump's Tariff Threats Spark Global Market Reactions

Updated Category News Views 163

Market Reactions to Tariff Developments As global markets navigate uncertain waters today, optimism and anxiety intertwine. The US dollar has taken a slight step higher, while gold has seen a dip, all stemming from ongoing trade tensions and recent tariff announcements by President Trump. With negotiations that are seen as promising but fraught with complexities, the...

Continue Reading
Sutro Biopharma's Upcoming Presentation at J.P. Morgan Event

Updated Category News Views 228

Sutro Biopharma's Upcoming Conference Presentation Sutro Biopharma, Inc. (NASDAQ: STRO), a trailblazer in oncology therapies based in South San Francisco, has some exciting news. The company announced that its Chief Executive Officer, Bill Newell, will be presenting at the prestigious J.P. Morgan Healthcare Conference. This annual event is a pivotal opportunity for...

Continue Reading
Nightly Launches Ambitious $25 Million Experience Initiative

Updated Category News Views 302

Nightly Introduces a $25 Million Initiative In a bold move to reshape the live entertainment landscape, Nightly has announced a substantial $25 million initiative aimed at expanding its dynamic experiences across the nation. Originating from Dallas, Nightly has quickly evolved into a cultural movement that seeks to redefine nightlife specifically for Gen Z audiences. This...

Continue Reading
Tecan Announces 2024 Results, Focuses on Growth and Innovation

Updated Category News Views 609

Tecan Reports 2024 Financial Results Amid Market Challenges Overview of Financial Highlights Tecan has unveiled its financial results for 2024, showcasing a robust commitment to enhancing operational resilience in a challenging market environment. Sales figures totaled CHF 934.3 million, marking a decline from the previous year's CHF 1,074.4 million. This 13.0% drop in...

Continue Reading
Auddia, Inc. (AUUD) Merger: Shareholder Alert and Investigation Insights

Updated Category News Views 227

Auddia, Inc. (NASDAQ: AUUD) is under the microscope after news broke about its proposed merger with McCarthy Finney, Inc., which sent shockwaves through trader desks and shareholder circles alike. The date was February 18, 2026, when class action attorney Juan Monteverde announced an investigation into the deal that’s left many scratching their heads about whether this...

Continue Reading